MERCK KGAA UNSP ADR Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
Merck KGaA Offers To Acquire Versum Materials For $48 Per Share
Article By: The Fly
Wednesday, February 27, 2019 9:25 AM EDT
Merck KGaA has proposed to the board of directors of Versum Materials that Merck should acquire all of the issued and outstanding common shares of Versum for $48 per share or an enterprise value of $5.9B in an all-cash transaction.
In this article: MKGAY, VSM
Read
Immuno-Oncology Promises Continued Wealth And Health: LifeTech Capital's Stephen Dunn
Article By: The Life Sciences Report
Monday, February 23, 2015 3:42 PM EDT
Immuno-oncology took center stage in the drug development world in 2014. But can this preeminence continue in 2015? In this interview, Stephen Dunn of LifeTech Capital outlines how companies are leveraging these therapies, and where investors should look for opportunity in the sector.
In this article: MRK, BMY, RHHBY, ESRX, PFE, MKGAY, AZN, KITE, JUNO, NVS, DNDN, JNJ, AMGN, XON, ZIOP, CBMG
Read

PARTNER HEADLINES

Latest Tweets for $MKGAY

No tweets yet!